Get the Stockscreener App
2.32
1.28%
-0.03
After Hours:
2.32
China Sxt Pharmaceuticals Inc stock is traded at $2.32, with a volume of 16,345.
It is down -1.28% in the last 24 hours and up +46.84% over the past month.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
See More
Previous Close:
$2.35
Open:
$2.33
24h Volume:
16,345
Relative Volume:
0.22
Market Cap:
$10.34M
Revenue:
$1.54M
Net Income/Loss:
$-8.87M
P/E Ratio:
-0.0654
EPS:
-35.4915
Net Cash Flow:
$-2.74M
1W Performance:
+48.72%
1M Performance:
+46.84%
6M Performance:
-99.06%
1Y Performance:
-99.11%
1-Day Range:
$2.31
$2.46
1-Week Range:
$1.59
$2.7699
52-Week Range:
$1.2501
$1,046.98
China Sxt Pharmaceuticals Inc Stock (SXTC) Company Profile
Compare SXTC vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SXTC
China Sxt Pharmaceuticals Inc
|
2.32 | 10.48M | 1.54M | -8.87M | -2.74M | -35.49 |
TAK
Takeda Pharmaceutical Co Adr
|
15.66 | 49.83B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.09 | 40.04B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.91 | 39.23B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
79.33 | 33.52B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
548.27 | 23.33B | 3.17B | 1.29B | 1.01B | 27.09 |
China Sxt Pharmaceuticals Inc Stock (SXTC) Latest News
China SXT Pharmaceuticals Company Profile & Introduction - Moomoo
China SXT Pharmaceuticals Shares Surge Over 25% After Hours: Here's Why - Sahm
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
China SXT Pharmaceuticals shares surge over 25% after hours: Here's why - MSN
China SXT Pharmaceuticals Launches $100 Million ATM Equity Program with Univest Securities - The Globe and Mail
China SXT Pharmaceuticals (SXTC) launches $100M ATM offering with Univest - Stock Titan
China SXT (NASDAQ: SXTC) sets up $100M at-the-market share offering - Stock Titan
China SXT Pharmaceuticals (SXTC) Surges 7%: Potential Breakout Above ResistanceTriple MA Cross - newsline.com
China SXT Pharmaceuticals (SXTC) Slips 3% as Stock Tests Key Support LevelsSkew Index - newsline.com
SXTC Faces Selling Pressure: Key Levels to Watch After 7.3% DeclineStraddle Setup - newsline.com
China SXT Pharmaceuticals (SXTC) Sees Uptick Amid Support HoldingVolume Rate Change - Newser
SXTC Should I Buy - Intellectia AI
TradingKey - TradingKey
SXTC Technical Analysis | Trend, Signals & Chart Patterns | CHINA SXT PHARMACEUTICALS-A (NASDAQ:SXTC) - ChartMill
China SXT Pharmaceuticals Raises $3.5 Million in Offshore Private Placement - The Globe and Mail
China SXT Pharmaceuticals Inc (SXTC) - MSN
China SXT (NASDAQ: SXTC) prices $3.5M Reg S share and warrant deal - Stock Titan
MSN Money - MSN
SXTC Stock Price, Quote & Chart | CHINA SXT PHARMACEUTICALS-A (NASDAQ:SXTC) - ChartMill
What guidance trend China SXT (SXTC)? (Bearish Momentum) 2026-04-29Volume Breakout - newser.com
China SXT Pharmaceuticals (SXTC) Co-CEO reports indirect Class B stake - Stock Titan
China SXT Pharmaceuticals (SXTC) CFO listed as insider in Form 3 - Stock Titan
China SXT Pharmaceuticals (SXTC) director Chee Yong Lip files Form 3 - Stock Titan
Director Ji Xiaodong files Form 3 for China SXT (SXTC) - Stock Titan
Director Liu Tong Tony files Form 3 at China SXT (SXTC) - Stock Titan
Co-CEO Simon Lim listed in China SXT (SXTC) Form 3 with no trades - Stock Titan
[Form 3] China SXT Pharmaceuticals, Inc. Initial Statement of Beneficial Ownership - Stock Titan
China SXT (SXTC) Sector Leadership | Q1 2025: Earnings ReportCommunity Sell Signals - Xã Thanh Hà
China SXT (SXTC) Stock: Why Industry Position (Bullish Sentiment) 2026-04-22Cash Flow - Cổng thông tin điện tử tỉnh Lào Cai
China SXT (SXTC) Stock Days to Cover (Smart Money Exits) 2026-04-15Crowd Risk Alerts - Cổng thông tin điện tử tỉnh Tây Ninh
Form 424B5Prospectus [Rule 424(b)(5)] - ADVFN
China SXT Pharmaceuticals Raises $760,000 in Registered Share Offering - The Globe and Mail
China SXT Pharmaceuticals announces $760,000 share offering on Monday By Investing.com - Investing.com India
China SXT Pharmaceuticals announces $760,000 share offering on Monday - Investing.com
SXTC (NASDAQ: SXTC) sells 2M Class A shares at $0.38 for $760K - Stock Titan
China SXT (SXTC) raises about $760K in 2M-share stock offering - Stock Titan
Breakout Move: Is China SXT Pharmaceuticals Inc undervalued by DCF analysisEarnings Growth Summary & Technical Buy Zone Confirmation - baoquankhu1.vn
Is China SXT (SXTC) Stock Growing Now | Price at $1.90, Up 0.53%Bollinger Squeeze - The Legal Advocate
Calendrier des fractionnements d'actions pour: - Yahoo Finance France
Aug Action: What is the target price for China SXT Pharmaceuticals Inc stockTrend Reversal & Target Return Focused Picks - baoquankhu1.vn
Macro Review: Does China SXT Pharmaceuticals Inc align with a passive investing strategy2026 Closing Moves & Weekly Top Gainers Trade List - baoquankhu1.vn
Levels Update: Does China SXT Pharmaceuticals Inc align with a passive investing strategySell Signal & AI Enhanced Trading Alerts - baoquankhu1.vn
China SXT Pharmaceuticals, Inc. (SXTC) - MSN
China SXT Pharmaceuticals implements dual-class share structure - Investing.com
China SXT gives new Class B shares 50 votes each in reclassification - Stock Titan
China SXT Pharmaceuticals, Inc. Announces Share Re-classification - Yahoo Finance
China Sxt Pharmaceuticals Inc Stock (SXTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):